NOVADIA

novadia-logo

Novadia provides cloud and application deployment, web designing, hosting consulting and training services.

#SimilarOrganizations #Website #More

NOVADIA

Social Links:

Industry:
Consulting Data Center Training Web Design Web Hosting

Address:
Eysins, Geneve, Switzerland

Country:
Switzerland

Website Url:
http://www.novadia.com

Total Employee:
11+

Status:
Active

Contact:
+41 22 595 1974

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible ThemePunch Bing Maps Map Point


Similar Organizations

not_available_image

Asterisk kompakt

Asterisk kompakt offers web design, consulting and web hosting services.

data-solution-logo

Data Solution

Data Solution specializes in web designing, hosting, consulting, domain registration, and graphic design services.

divioseo-logo

Divioseo

Divioseo provides mobile applications to boost the digital presence and grow the audience.

easiwebs-solutions-logo

Easiwebs Solutions

Easiwebs Solutions provides web hosting, web design, branding, and training services.

Official Site Inspections

http://www.novadia.com

  • Host name: 217.19.237.54.static.hosted.by.combell.com
  • IP address: 217.19.237.54
  • Location: Brussels Belgium
  • Latitude: 50.8336
  • Longitude: 4.3337
  • Timezone: Europe/Brussels
  • Postal: 1060

Loading ...

More informations about "Novadia"

Novadip Biosciences - Crunchbase Company Profile

Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft โ€ฆSee details»

NOVADIP Biosciences S.A. - LinkedIn

Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration technology platform. | Novadip Biosciences is a clinical-stage biopharmaceutical company founded to design ...See details»

InvestEU in Belgium: EIB venture debt for bone therapy ... - Novadip

Dec 21, 2023 The EIB has signed an โ‚ฌ18 million venture debt deal with Belgian biotech company Novadip funding innovation on its therapies for rare bone-related genetic diseases. โ€ฆSee details»

Novadip Biosciences SA:Company Profile & Technical โ€ฆ

Novadip Biosciences SA is a company that provides Bone defect, Pharmacy and Therapeutics, Stem cell and more. Novadip Biosciences SA is headquartered in Belgium Brabant wallon. โ€ฆSee details»

Novadip Biosciences S.A. - life-sciences-europe.com

Founded by Prof. Denis Dufrane and Jean-François Pollet, NOVADIP BIOSCIENCES, a spin-off company from University of Louvain (UCL) and Saint-Luc University Hospital (CUSL), is active โ€ฆSee details»

Novadip Biosciences (SA) - Mont-Saint-Guibert (1435)

Consultez toutes les données de l'entreprise Novadip Biosciences située à Mont-Saint-Guibert avec le numéro de TVA BE0535575602.See details»

Eric Paul Pâques, PhD | Novadip | Chairman | Expert

Dr. Eric Paul Pâques joined the company as Non-Executive Chairman of the Board of Directors in 2017.See details»

Innovation in Tissue Regeneration Improves Spine Fusions and โ€ฆ

Nov 21, 2022 Novadip Biosciences recently received an infusion of โ‚ฌ40 million (~USD $40 million) in investments, increasing its total funding to โ‚ฌ88 million. The Belgium-based company โ€ฆSee details»

Global Business Reports - Denis Dufrane

Apr 28, 2023 Can you present Novadip, your pipeline, and the 3M3 tissue regeneration platform? Novadip Biosciences is a clinical-stage biopharmaceutical company founded to design, develop, and bring to the market a new class of โ€ฆSee details»

Belgium: InvestEU - EIB venture debt for bone therapy โ€ฆ

Dec 14, 2023 The European Investment Bank (EIB) and Novadip have signed a โ‚ฌ18 million venture debt financing agreement supported by the European Unionโ€™s InvestEU initiative. The Belgian biotech company will use the funds to support โ€ฆSee details»

Series B - Novadip Biosciences - 2021-10-28 - Crunchbase

Oct 28, 2021 Novadip Biosciences raised $22196495 on 2021-10-28 in Series BSee details»

NVD-X3 | Novadip | For Common Orthopedic Conditions

NVD-X3 is in clinical development for common orthopedic conditions, with learnings from Novadipโ€™s earlier autologous clinical programs.See details»

EXECUTIVE INTERVIEW - Novadip Biosciences: Developing a New โ€ฆ

Denis Dufrane, MD, PhD, Chief Executive Officer, and Founder of Novadip Biosciences, discusses his companyโ€™s innovative approach to tissue regeneration technology.See details»

Novadip Biosciences raises โ‚ฌ40M for bone treatments - Labiotech.eu

Nov 4, 2022 Novadip Biosciences is developing new regenerative tissue products to speed healing of large bone defects and injuries in a single treatment.See details»

Denis Dufrane Presents Novadip Biosciences at LSI USA '24

Denis Dufrane Presents Novadip Biosciences at LSI USA '24 Novadip is a clinical-stage company developing breakthrough stem cell-based tissue regeneration therapies to accelerate healing โ€ฆSee details»

Novadip shares positive 12-month results from phase 1b/2a trial โ€ฆ

Feb 20, 2025 Novadipโ€™s pipeline includes two lead products: NVD003, an autologous cell-based therapy currently in phase 1b/2a clinical trials in adults with bone nonunion, and pediatric โ€ฆSee details»

NVD-003 | Novadip | Critical Size Bone Reconstruction

NVD-003 is a single treatment for critical size bone reconstruction, which is comprised of differentiated stem cells within an extracellular matrix resulting in active local delivery of highly โ€ฆSee details»

Novadip shares positive 12-month results from phase 1b/2a trial โ€ฆ

Feb 20, 2025 Mont Saint-Guibert, Belgium, February 20, 2025 โ€“ Novadip Biosciences, a clinical stage biotechnology company specializing in regenerative medicine, today announces the โ€ฆSee details»

Reconstruction osseuse: "Cette autorisation aux Etats-Unis est une ...

Nov 20, 2024 Novadip Biosciences vient d'obtenir le feu vert des autorités américaines pour démarrer une étude clinique sur la fusion vertébrale. Il s'agit de l'avant-dernière marche avant โ€ฆSee details»

Hara Episkopou, PhD | Novadip | Head of Discovery 2020

Dr. Hara Episkopou joined Novadip in 2020 with 14 years of experience in cancer research of identifying new therapeutic targets for the treatment of cancersSee details»

linkstock.net © 2022. All rights reserved